PT1133296E - Nova aplicacao terapeutica da nicergolina - Google Patents

Nova aplicacao terapeutica da nicergolina

Info

Publication number
PT1133296E
PT1133296E PT99956109T PT99956109T PT1133296E PT 1133296 E PT1133296 E PT 1133296E PT 99956109 T PT99956109 T PT 99956109T PT 99956109 T PT99956109 T PT 99956109T PT 1133296 E PT1133296 E PT 1133296E
Authority
PT
Portugal
Prior art keywords
nicergolin
new
therapeutic application
therapeutic
application
Prior art date
Application number
PT99956109T
Other languages
English (en)
Inventor
Michel Dib
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PT1133296E publication Critical patent/PT1133296E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT99956109T 1998-11-24 1999-11-22 Nova aplicacao terapeutica da nicergolina PT1133296E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814793A FR2786100B1 (fr) 1998-11-24 1998-11-24 Nouvelle application therapeutique de la nicergoline

Publications (1)

Publication Number Publication Date
PT1133296E true PT1133296E (pt) 2003-11-28

Family

ID=9533130

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99956109T PT1133296E (pt) 1998-11-24 1999-11-22 Nova aplicacao terapeutica da nicergolina

Country Status (11)

Country Link
US (2) US6469019B2 (pt)
EP (1) EP1133296B1 (pt)
JP (1) JP4637359B2 (pt)
AT (1) ATE246924T1 (pt)
AU (1) AU1278600A (pt)
DE (1) DE69910425T2 (pt)
DK (1) DK1133296T3 (pt)
ES (1) ES2200569T3 (pt)
FR (1) FR2786100B1 (pt)
PT (1) PT1133296E (pt)
WO (1) WO2000030643A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786101B1 (fr) * 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
BRPI0519642A8 (pt) * 2004-12-29 2017-10-03 Hill´S Pet Nutrition Inc Método para inibir um declínio em aprendizagem e/ou memória, kit apropriado para administrar um ou mais antioxidantes a um animal, meio para transmitir informação, e, uso de uma composição
US8148325B2 (en) 2004-12-30 2012-04-03 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
BRPI0613000A2 (pt) * 2005-07-14 2012-12-04 Hills Pet Nutrition Inc método para aumentar a longevidade de um animal, artigo de fabricação, kit, e, meio de comunicação de informação acerca de ou instruções para a administração a um animal velho de uma composição
DE102007052536A1 (de) * 2007-11-01 2009-05-07 Beiersdorf Ag Wirkstoffkombinationen aus Anisfruchtextrakt und Weißen Teeextrakt
FR3000746A1 (fr) 2013-01-04 2014-07-11 Centre Nat Rech Scient Peptide pour son utilisation dans le traitement des neuronopathies motrices

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228943A (en) 1962-06-11 1966-01-11 Lumilysergol derivatives
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
IT1252163B (it) * 1991-12-03 1995-06-05 Poli Ind Chimica Spa Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica
JP2864885B2 (ja) * 1992-07-02 1999-03-08 田辺製薬株式会社 ニセルゴリン含有経口投与製剤
IT1256743B (it) * 1992-12-18 1995-12-15 Giorgio Pifferi Composizioni farmaceutiche a rilascio controllato contenenti nicergolina
FR2786101B1 (fr) * 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite

Also Published As

Publication number Publication date
AU1278600A (en) 2000-06-13
JP2002530336A (ja) 2002-09-17
DE69910425D1 (de) 2003-09-18
FR2786100B1 (fr) 2002-03-01
WO2000030643A1 (fr) 2000-06-02
US20010044448A1 (en) 2001-11-22
US6469019B2 (en) 2002-10-22
JP4637359B2 (ja) 2011-02-23
ATE246924T1 (de) 2003-08-15
US20030134869A1 (en) 2003-07-17
ES2200569T3 (es) 2004-03-01
EP1133296A1 (fr) 2001-09-19
DE69910425T2 (de) 2004-04-08
EP1133296B1 (fr) 2003-08-13
FR2786100A1 (fr) 2000-05-26
DK1133296T3 (da) 2003-11-17

Similar Documents

Publication Publication Date Title
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
PT815087E (pt) Derivados de fenilo trissubstituidos
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
PT1133296E (pt) Nova aplicacao terapeutica da nicergolina
PT928193E (pt) Utilizacao de 1-hidroxi-2-piridonas para o tratamento de infeccoes da pele
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
IL143279A0 (en) Novel therapeutic application of low molecular weight heparin
NO20005548L (no) Mykobakterieinhibitorer
PT1133297E (pt) Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids
DE69720410D1 (de) Therapeutisches Mittel zur Behandlung hartnäckiger Hundedermatitis
NO984198L (no) FremgangsmÕte for behandling av aggresjon
BR9708037A (pt) Método para o tratamento de abuso de substância
ZA9610073B (en) Method of using beta-interferons to treat restenosis
BR1101180A (pt) formulação para tratamento de sintomas e doenças.
ITPD960107A0 (it) Associazione di porfirina cationica e sorgente luminosa coerente o noncoerente per il trattamento di infezioni microbiche dell'endodonto e del perimpianto
ITPD960038U3 (it) Associazione di porfirina cationica e sorgente luminosa coerente o non coerente per il trattamento di infezioni microbiche dell'endodonto e
UA8280A (uk) Спосіб лікування псоріазу